Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1E | P28566 | 3/20 | 0.63 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.63 |
| ▸ | LMNA | P02545 | 3/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.54 |
| ▸ | HTR1A | P08908 | 1/20 | 0.54 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.54 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.54 |
| ▸ | DRD1 | P21728 | 1/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.54 |
| ▸ | DRD3 | P35462 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28373611 | 0.98 | HTR1E (0.65) | HTR1ES1PR3LMNAMEN1KMT2A | |
| SCHEMBL1156417 | 0.90 | HTR1E (0.54) | HTR1ES1PR3LMNAMEN1KMT2A | |
| SCHEMBL12531975 | 0.89 | HTR1E (0.63) | HTR1ES1PR3LMNAMEN1KMT2A | |
| SCHEMBL67219 | 0.89 | HTR1E (0.63) | HTR1ES1PR3LMNAMEN1KMT2A | |
| SCHEMBL10298827 | 0.87 | LMNA (0.58) | HTR1ES1PR3LMNAMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL11526873 | 0.87 | HTR1E (0.61) | HTR1ES1PR3LMNAMEN1KMT2A | |
| SCHEMBL9780781 | 0.87 | HTR1E (0.61) | HTR1ES1PR3LMNAMEN1KMT2A | |
| SCHEMBL28622389 | 0.86 | HTR1E (0.65) | HTR1ES1PR3LMNAMEN1KMT2A | |
| SCHEMBL69127 | 0.86 | HTR1E (0.65) | HTR1ES1PR3LMNAMEN1KMT2A | |
| SCHEMBL14453324 | 0.85 | MEN1 (0.59) | HTR1ES1PR3LMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100179343-A1 | METHOD OF PRODUCING AN OPTICALLY ACTIVE CYANOHYDRIN DERIVATIVE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-07-15 | — | — | US | claimed |
| WO-2008121074-A1 | METHOD OF PRODUCING AN OPTICALLY ACTIVE CYANOHYDRIN DERIVATIVE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2008-10-09 | — | — | WO | claimed |
| EP-2714411-B1 | METHODS FOR THERMAL PRINTING OF PHOTONIC CRYSTAL MATERIALS, AND THERMALLY PRINTABLE PHOTONIC CRYSTAL MATERIALS AND ASSEMBLIES | OPALUX INCORPORATED (CA) | 2019-04-10 | — | — | EP | disclosed |
| US-9726783-B2 | Methods and systems for thermal printing of photonic crystal materials, and thermally printable photonic crystal materials and assemblies | OPALUX INCORPORATED (CA) | 2017-08-08 | — | — | US | disclosed |
| US-9599515-B2 | Temperature-responsive photonic crystal device | OPALUX INCORPORATED (US) | 2017-03-21 | — | — | US | disclosed |
| US-20140193649-A1 | Methods and Systems for Thermal Printing of Photonic Crystal Materials, and Thermally Printable Photonic Crystal Materials and Assemblies | OPALUX INCORPORATED (CA) | 2014-07-10 | — | — | US | disclosed |
| US-20130116438-A1 | IRIDIUM COMPLEX AND METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-05-09 | — | — | US | disclosed |
| WO-2012162805-A1 | METHODS AND SYSTEMS FOR THERMAL PRINTING OF PHOTONIC CRYSTAL MATERIALS, AND THERMALLY PRINTABLE PHOTONIC CRYSTAL MATERIALS AND ASSEMBLIES | OPALUX INCORPORATED (CA) | 2012-12-06 | — | — | WO | disclosed |
| US-20120044970-A1 | Temperature-Responsive Photonic Crystal Device | OPALUX INCORPORATED (CA) | 2012-02-23 | — | — | US | disclosed |
| EP-2401594-A1 | TEMPERATURE-RESPONSIVE PHOTONIC CRYSTAL DEVICE | Opalux Incorporated (CA) | 2012-01-04 | — | — | EP | disclosed |
| WO-2010096936-A1 | TEMPERATURE-RESPONSIVE PHOTONIC CRYSTAL DEVICE | OPALUX INCORPORATED (CA) | 2010-09-02 | — | — | WO | disclosed |
| US-7732544-B2 | Titanium compound and process for producing optically active cyanohydrins | MITSUI CHEMICALS, INC. (JP) | 2010-06-08 | — | — | US | disclosed |
| EP-1806336-B1 | TITANIUM COMPOUND AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYANOHYDRINS | MITSUI CHEMICALS INC (JP) | 2009-09-30 | — | — | EP | disclosed |
| WO-2008121074-A1 | METHOD OF PRODUCING AN OPTICALLY ACTIVE CYANOHYDRIN DERIVATIVE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2008-10-09 | — | — | WO | disclosed |
| US-20070265463-A1 | Titanium Compound and Process for Producing Optically Active Cyanohydrins | MITSUI CHEMICALS, INC. (JP) | 2007-11-15 | — | — | US | disclosed |
| EP-1806336-A1 | TITANIUM COMPOUND AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYANOHYDRINS | Mitsui Chemicals, Inc. (JP) | 2007-07-11 | — | — | EP | disclosed |
| US-6156940-A | Process for producing optically active carbinols | SUMIKA FINE CHEMICALS COMPANY, LIMITED (JP) | 2000-12-05 | — | — | US | disclosed |
| EP-0713848-B1 | Process for producing optically active carbinols | SUMIKA FINE CHEMICALS COMPANY (JP) | 1999-09-08 | — | — | EP | disclosed |
| US-5831132-A | REDUCING AGENT FROM BORANES AND AMINO ALCOHOLS | SUMIKA FINE CHEMICALS COMPANY, LTD. (JP) | 1998-11-03 | — | — | US | disclosed |
| EP-0713848-A1 | Process for producing optically active carbinols | SUMIKA FINE CHEMICALS Company, Limited (JP) | 1996-05-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100179343-A1 | METHOD OF PRODUCING AN OPTICALLY ACTIVE CYANOHYDRIN DERIVATIVE | TDO2, AOX1, DAO | HTR1E 1929/4885S1PR3 3295/4885LMNA 3219/4885 |
| US-20130116438-A1 | IRIDIUM COMPLEX AND METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND | PPIP5K2, INF2, IMPDH2 | HTR1E 2947/4885S1PR3 3370/4885LMNA 4866/4885 |
| US-20070265463-A1 | Titanium Compound and Process for Producing Optically Active Cyanohydrins | WNT1, C3AR1, TDO2 | HTR1E 3240/4885S1PR3 4144/4885LMNA 4117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.